MetLife Investment Management’s Guardian Pharmacy Services GRDN Stock Holding History

MetLife Investment Management’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$513K	Sell	12,258 -214	-2%	-$8.29K	﹤0.01%	1893
2026 Q1	$470K	Buy	12,472 +620	+5%	+$20.3K	﹤0.01%	1784
2025 Q4	$357K	Buy	11,852 +109	+0.9%	+$3.08K	﹤0.01%	1955
2025 Q3	$308K	Buy	11,743 +3,740	+47%	+$89.1K	﹤0.01%	2066
2025 Q2	$171K	Buy	8,003 +2,391	+43%	+$54K	﹤0.01%	2270
2025 Q1	$119K	Hold	5,612	–	–	﹤0.01%	2448
2024 Q4	$114K	Buy	+5,612	New	+$116K	﹤0.01%	2565

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

MetLife Investment Management's GRDN Position: Q2 2026 in Review

MetLife Investment Management reduced its Guardian Pharmacy Services (GRDN) stake by 1.7% in Q2 2026, selling an estimated $8.29K and leaving 12,258 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

MetLife Investment Management first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

MetLife Investment Management held 12,258 shares of Guardian Pharmacy Services worth $513K as of Q2 2026.
MetLife Investment Management sold 214 Guardian Pharmacy Services shares in Q2 2026, an estimated $8.29K.
Guardian Pharmacy Services made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1893 holding.
MetLife Investment Management first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.